全文获取类型
收费全文 | 105352篇 |
免费 | 6686篇 |
国内免费 | 442篇 |
专业分类
耳鼻咽喉 | 1149篇 |
儿科学 | 2680篇 |
妇产科学 | 1900篇 |
基础医学 | 13176篇 |
口腔科学 | 1830篇 |
临床医学 | 11214篇 |
内科学 | 21091篇 |
皮肤病学 | 1390篇 |
神经病学 | 10516篇 |
特种医学 | 4044篇 |
外国民族医学 | 3篇 |
外科学 | 16871篇 |
综合类 | 1193篇 |
一般理论 | 140篇 |
预防医学 | 8947篇 |
眼科学 | 2163篇 |
药学 | 6822篇 |
中国医学 | 120篇 |
肿瘤学 | 7231篇 |
出版年
2023年 | 578篇 |
2022年 | 960篇 |
2021年 | 2166篇 |
2020年 | 1368篇 |
2019年 | 2158篇 |
2018年 | 2638篇 |
2017年 | 1885篇 |
2016年 | 2067篇 |
2015年 | 2343篇 |
2014年 | 3543篇 |
2013年 | 4894篇 |
2012年 | 7763篇 |
2011年 | 8191篇 |
2010年 | 4697篇 |
2009年 | 4244篇 |
2008年 | 7348篇 |
2007年 | 7669篇 |
2006年 | 7363篇 |
2005年 | 7091篇 |
2004年 | 6898篇 |
2003年 | 6230篇 |
2002年 | 5855篇 |
2001年 | 996篇 |
2000年 | 707篇 |
1999年 | 1005篇 |
1998年 | 1270篇 |
1997年 | 975篇 |
1996年 | 803篇 |
1995年 | 736篇 |
1994年 | 634篇 |
1993年 | 635篇 |
1992年 | 575篇 |
1991年 | 520篇 |
1990年 | 454篇 |
1989年 | 379篇 |
1988年 | 377篇 |
1987年 | 392篇 |
1986年 | 326篇 |
1985年 | 390篇 |
1984年 | 383篇 |
1983年 | 313篇 |
1982年 | 366篇 |
1981年 | 314篇 |
1980年 | 252篇 |
1979年 | 149篇 |
1978年 | 165篇 |
1977年 | 132篇 |
1975年 | 119篇 |
1974年 | 113篇 |
1973年 | 114篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
961.
A 43-year-old female with a remote history of surgical closureof an atrial septal defect with 相似文献
962.
Guagliumi G Stone GW Cox DA Stuckey T Tcheng JE Turco M Musumeci G Griffin JJ Lansky AJ Mehran R Grines CL Garcia E 《Circulation》2004,110(12):1598-1604
963.
964.
Thombs BD Fuss S Hudson M Schieir O Taillefer SS Fogel J Ford DE Baron M;Canadian Scleroderma Research Group 《Arthritis and rheumatism》2008,59(3):431-437
OBJECTIVE: Between 36% and 65% of patients with systemic sclerosis (SSc) report symptoms of depression above cutoff thresholds on self-report questionnaires. The objective of this study was to assess whether these high rates result from differential reporting of somatic symptoms related to the high physical burden of SSc. METHODS: Symptom profiles reported on the Center for Epidemiologic Studies Depression Scale (CES-D) were compared between a multicenter sample of 403 patients with SSc and a sample of respondents to an Internet depression survey, matched on total CES-D score, age, race/ethnicity, and sex. An exact nonparametric generalized Mantel-Haenszel procedure was used to identify differential item functioning between groups. RESULTS: Patients with SSc reported significantly higher frequencies (moderate to large effect size; P < 0.01) on 4 CES-D somatic symptom items: bothered, appetite, effort, and sleep. Internet respondents had higher item scores on 2 items that assessed interpersonal difficulties (unfriendly, large effect size; P < 0.01; disliked, large effect size; P < 0.01) and on 2 items that assessed lack of positive effect (happy, moderate effect size; P = 0.01; enjoy, large effect size; P < 0.01). Adjustment of standard CES-D cutoff criteria for potential bias due to somatic symptom reporting resulted in a reduction of only 3.6% in the number of SSc patients with significant symptoms of depression. CONCLUSION: High rates of depressive symptoms in SSc are not due to bias related to the report of somatic symptoms. The pattern of differential item functioning between the SSc and Internet groups, however, suggests some qualitative differences in depressive symptom presentation. 相似文献
965.
966.
Lewinsohn DA Heinzel AS Gardner JM Zhu L Alderson MR Lewinsohn DM 《American journal of respiratory and critical care medicine》2003,168(11):1346-1352
Both CD4+ and CD8+ T cells are important for successful immunity to tuberculosis and have redundant effector functions, such as cytolysis and release of potent antimycobacterial cytokines such as interferon-gamma and tumor necrosis factor-alpha. We hypothesized that CD8+ T cells play a unique role in host defense to Mycobacterium tuberculosis infection as well. Possibilities include preferential and/or enhanced release of granular constituents and/or preferential recognition of heavily infected cells. Utilizing human, Mycobacterium tuberculosis-specific, CD4+ and CD8+ T cell clones, we demonstrate that, after recognition of antigen-presenting cells displaying peptide antigen, CD4+ T cells preferentially release interferon-gamma, whereas CD8+ T cells preferentially lyse antigen-presenting cells. Furthermore, utilizing dendritic cells infected with Mycobacterium tuberculosis expressing green fluorescent protein, we show that CD8+ T cells preferentially recognize heavily infected cells that constitute the minority of infected cells. These data support the hypothesis that the central role of CD8+ T cells in the control of infection with Mycobacterium tuberculosis may be that of surveillance; in essence, recognition of cells in which the containment of Mycobacterium tuberculosis is no longer effective. 相似文献
967.
Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality 总被引:5,自引:0,他引:5
Russo MW Sood A Jacobson IM Brown RS 《The American journal of gastroenterology》2003,98(11):2521-2527
OBJECTIVES: Transjugular intrahepatic portosystemic shunt (TIPS) is frequently used to treat patients with refractory ascites, but its role is controversial. We sought to determine from the literature the efficacy, morbidity, and mortality associated with TIPS for refractory ascites. METHODS: We searched MEDLINE and identified studies published in English from January, 1985, to March, 2003, that evaluated the effect of TIPS in patients with refractory ascites. Outcomes that were analyzed included complete resolution of ascites, reduction in ascites, mortality, encephalopathy, stenosis, and renal function. Data were analyzed on an intention to treat basis. RESULTS: Of 25 studies identified, 16 were included in the analysis. The pooled estimate for complete response at 6 months was 45% and for any response (complete and partial) was 63%. Pooled 6-month mortality after TIPS was 36%. Risk factors for mortality included renal insufficiency (serum creatinine >1.5 mg/dl), hyperbilirubinemia (total bilirubin >3 mg/dl), advanced age (>60 yr), and poor response to TIPS. The pooled rate of new or worsening encephalopathy after TIPS was 32%. In most cases, encephalopathy was managed medically or by reduction in shunt size; however, refractory cases were associated with 100% mortality in most studies. Studies reporting the effect of TIPS on kidney function showed improvement in creatinine clearance and urinary sodium excretion. CONCLUSIONS: TIPS is effective in eliminating ascites or substantially reducing ascites in cases refractory to medical therapy. Renal insufficiency, refractory encephalopathy, and hyperbilirubinemia were consistently associated with mortality after TIPS. In individuals with risk factors for mortality, alternative strategies should be recommended. 相似文献
968.
Matricellular proteins are extracellular matrix proteins that modulate cell-matrix interactions and cell function, and do not seem to have a direct structural role. The family includes tenascin-C (TN-C), tenascin-X (TN-X), osteonectin, osteopontin, thrombospondin-1 (TSP1) and thrombospondin-2 (TSP2). Expression of matricellular proteins is high during embryogenesis, but almost absent during normal postnatal life. Interestingly, it re-appears in response to injury. Left ventricular remodeling is a complicated process that occurs in the stressed heart, and is still not completely understood. Several members of the matricellular protein family, like tenascin-C, osteopontin, and osteonectin are up-regulated after cardiac injury. Therefore, this group of proteins may have crucial functions in the heart coping with stress. This review will focus on the expression, regulation and function of these matricellular proteins, and will discuss the crucial functions that these proteins might exert during remodeling of the stressed heart. 相似文献
969.
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis 总被引:1,自引:0,他引:1
Mason U Aldrich J Breedveld F Davis CB Elliott M Jackson M Jorgensen C Keystone E Levy R Tesser J Totoritis M Truneh A Weisman M Wiesenhutter C Yocum D Zhu J 《The Journal of rheumatology》2002,29(2):220-229
OBJECTIVE: Double blind studies were conducted with the anti-CD4 monoclonal antibody (Mab) keliximab in patients with active, stable rheumatoid arthritis (RA), to confirm preliminary evidence of efficacy and safety from open. uncontrolled studies. METHODS: We enrolled 136 and 186 patients into 2 consecutive, randomized, double blind trials, with similar populations [apart from inclusion of disease modifying antirheumatic drug (DMARD)-na?ve patients in Study 2]. Patients received 4 weeks intravenous placebo or keliximab [40, 80, 120, or 140 mg twice weekly (bw), or 240 mg once weekly (ow)].The primary endpoint was the American College of Rheumatology (ACR) 20 response criteria, one week after the end of treatment. RESULTS: ACR 20 response rates in Study I were 19%, 42%, 51%*, and 69%* (*p < 0.05 compared to placebo), with placebo, 40, 80, or 140 mg keliximab bw, respectively. The response rates in Study 2 were 30%, 39%, 46% and 47% with placebo, 80 or 120 mg bw, or 240 mg keliximab ow, respectively. In the 2 studies, there was a dose dependent increase in peripheral blood CD4+ T cell coating with keliximab, but a different pattern of CD4 depletion was seen. While only 12% of keliximab treated patients in Study I had CD4 counts below 250 cells/mm3 at the end of the treatment period, 47% fell below this level in Study 2. Clinical response was not correlated with CD4 depletion, but was correlated with CD4+ T cell coating with keliximab. CONCLUSION: Coating of peripheral blood CD4+ T cells with keliximab, but not CD4 depletion, is a determinant of clinical response. 相似文献
970.